Med Learning Group

This immersive experience has been designed for pediatricians, pediatric dermatologists and other healthcare professionals involved in the management of pediatric patients who may have diseases driven in part by type 2 inflammation such as moderate-to-severe atopic dermatitis, moderate-to-severe asthma and eosinophilic esophagitis. Specifically, the programming will utilize a range of live experiences to help clinicians describe patient-specific strategies to select appropriate therapies; integrate biologic therapies based on the latest clinical evidence into effective therapeutic algorithms and action plans for type 2 inflammation; and develop evidence-based strategies for managing the diseases.

Come speak to our holographic AI patients, view our virtual reality learning experiences and gain access to clinical practice tools to better manage and educate your patients in practice.